Sotera Health Company

SHC Healthcare Diagnostics & Research

Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.

Revenue
+4.36%
EPS
+20.1%
Free cash flow
+65.0%
Total debt
+0.14%

Quarter to September 2026, against a year earlier

15.87 0.00 0.00%
Market cap
$4.5B
P/E
26.3×
Fwd P/E
26.4×
Dividend yield
—
F-score
7/9
Altman Z
1.76
Beneish M
−2.75
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

65.33 34.98 31.14 30.60
P/S ratio
4.30 3.44 4.17 4.30
P/FCF ratio
33.58 42.18 45.01 39.05
P/Operating CF
48.58 138.79 57.32 47.83
P/B ratio
8.27 6.56 7.62 7.21
EV/Sales
5.93 5.05 5.71 5.79
EV/EBITDA
13.68 11.69 13.10 13.25
EV/FCF
46.23 61.96 61.64 52.55
Current Ratio
2.46 2.82 2.80 3.13
Net Debt/EBITDA
13.55 17.72 13.22 12.38
Debt/Equity
3.69 3.58 3.35 3.06
Earnings Yield
1.53% 2.86% 3.21% 3.27%
Free Cash Flow Yield
2.98% 2.37% 2.22% 2.56%
Free Cash Flow per Share
0.18 (0.06) 0.15 0.20
Book value per Share
2.13 2.19 2.33 2.56
Free Cash Flow
52.41 (16.73) 42.05 57.71
EV/EBIT
19.05 15.76 17.40 17.72
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026